These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 14567521

  • 1. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE, Rubin BK.
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [Abstract] [Full Text] [Related]

  • 2. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS, Rubin BK.
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 4. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 5. Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis.
    Cervin A, Wallwork B.
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1339-50. PubMed ID: 16326189
    [Abstract] [Full Text] [Related]

  • 6. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M, Henke MO, Rubin BK.
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [Abstract] [Full Text] [Related]

  • 7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 8. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V, Bosnar M, Kragol G.
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [Abstract] [Full Text] [Related]

  • 9. Macrolide therapy of chronic rhinosinusitis.
    Cervin A, Wallwork B.
    Rhinology; 2007 Dec; 45(4):259-67. PubMed ID: 18085018
    [Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS, Egan M, Kazmierczak BI.
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [Abstract] [Full Text] [Related]

  • 11. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P, Fabbri LM, Bush A.
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.
    Harvey RJ, Wallwork BD, Lund VJ.
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):689-703. PubMed ID: 19879444
    [Abstract] [Full Text] [Related]

  • 13. Antibiotics as immunomodulant agents in COPD.
    Blasi F, Mantero M, Aliberti S.
    Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
    [Abstract] [Full Text] [Related]

  • 14. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K, Kastelik J, Morjaria JB.
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [Abstract] [Full Text] [Related]

  • 15. Macrolides in cystic fibrosis.
    McArdle JR, Talwalkar JS.
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [Abstract] [Full Text] [Related]

  • 16. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms.
    Altenburg J, de Graaff CS, van der Werf TS, Boersma WG.
    Respiration; 2011 Dec; 81(1):67-74. PubMed ID: 20733281
    [Abstract] [Full Text] [Related]

  • 18. Anti-inflammatory effects of macrolides in childhood lung diseases.
    Luisi F, Gandolfi TD, Daudt AD, Sanvitto JP, Pitrez PM, Pinto LA.
    J Bras Pneumol; 2012 Dec; 38(6):786-96. PubMed ID: 23288126
    [Abstract] [Full Text] [Related]

  • 19. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N, Lipton JH, Chan CK, Marras TK.
    Bone Marrow Transplant; 2009 Jul; 44(2):69-73. PubMed ID: 19430505
    [Abstract] [Full Text] [Related]

  • 20. [Usefulness of macrolides as anti-inflammatories in respiratory diseases].
    Sevilla-Sánchez D, Soy-Muner D, Soler-Porcar N.
    Arch Bronconeumol; 2010 May; 46(5):244-54. PubMed ID: 19962815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.